3.9 Article

The Role of 99mTc-antigranulocyte SPECT/CT In Community-Acquired Diabetic Foot Osteomyelitis: A Clinical Experience

Journal

CURRENT DIABETES REVIEWS
Volume 18, Issue 6, Pages -

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1573399817666210503140303

Keywords

Anti-granulocyte SPECT/CT; diabetic foot; osteomyelitis; clinical benefit; magnetic resonance imaging; comparisons

Ask authors/readers for more resources

This study evaluated the clinical value of 99mTc-antigranulocyte SPECT/CT in DFO patients and found that it did not change the clinical approach.
Background: Magnetic resonance imaging (MRI) is the actual gold standard for the radiological diagnosis of diabetic foot osteomyelitis (DFO). Materials and Methods: MRI is not always available and many patients have contraindications. We evaluated the clinical value of 99mTc-antigranulocyte SPECT/CT (AGS) in eight DFO patients who underwent MRI before. Results: The goal was to have a better clinical view on the extent of bone infection and to ameliorate the surgical approach for DFO. However, this additional scintigraphy did not change anything in the clinical approach. Conclusion: We shared our experience with AGS for clinical management of complex DFO cases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available